Clinical moderators of response to nalmefene in a randomized-controlled trial for alcohol dependence: An exploratory analysis
Authors:
- 18 February 2022
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 233, 109365
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month StudiesAlcohol and Alcoholism, 2013
- Conceptualizing withdrawal-induced escalation of alcohol self-administration as a learned, plasticity-dependent processAlcohol, 2012
- κ-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent ratsNeuropharmacology, 2011
- Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementationAddictive Behaviors, 2011
- Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbensPsychopharmacology, 2010
- OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based ApproachAlcohol, Clinical and Experimental Research, 2009
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialtyDrug and Alcohol Dependence, 2009
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Dynorphin and the pathophysiology of drug addictionPharmacology & Therapeutics, 2007
- Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol DependenceNeuropsychopharmacology, 2007